Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
The Journal of Pharmacy and Pharmacology|January 1, 1975
A crystallographic and theoretical study of the conformation of DOET and its significance for the hallucinogenic amphetaminesA S Horn, M L Post, O Kennard, et al.European Journal of Pharmacology|May 28, 1985
Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranesT B Mulder, C J Grol, D Dijkstra, et al.European Journal of Pharmacology|March 17, 1987
A comparison of the pharmacological actions of 4-aminopyridine and two of its derivatives in the monkeyP T Biessels, M C Houwertjes, S Agoston, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1990
Transdermal administration of the dopamine agonist N-0437 and seven ester prodrugs: comparison with oral administration in the 6-OHDA turning modelI den Daas, P G Tepper, H Rollema, et al.European Journal of Pharmacology|April 9, 1981
Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTNC Sumners, J B De Vries, D Dijkstra, et al.European Journal of Pharmacology|March 4, 1983
trans-N-n-Propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptorsJ C Van Oene, H A Houwing, D Dijkstra, et al.Biochemical Pharmacology|October 15, 1988
Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human plateletsE A Biessen, J A Norder, A S Horn, et al.European Journal of Pharmacology|October 1, 1984
N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonistsM Beaulieu, Y Itoh, P Tepper, et al.Journal of Medicinal Chemistry|August 1, 1980
Conformationally restricted phenothiazine neuroleptics. 1. 3-(Dimethylamino)-1,2,3,4-tetrahydroazepino[3,2,1-kl]phenothiazineA R Martin, S H Kim, H I Yamamura, et al.The Journal of Pharmacy and Pharmacology|December 1, 1983
The purported dopamine agonist DPI inhibits [3H]noradrenaline release from rat cortical slices but not [3H]dopamine and [14C]acetylcholine release from rat striatal slices in-vitroJ C Van Oene, P Sminia, A H Mulder, et al.Pageof 13